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Few studies have been published on airway resistance measurements using the inter-
rupter technique (IT). We performed a cross-sectional study, evaluating 38 children
and adolescents with Cystic Fibrosis (CF), followed at the outpatient CF clinic of
Hospital Sa˜o Lucas from Pontifı´cia Universidade Cato´lica do Rio Grande do Sul.
Airway resistance (Rint) was measured by the IT, followed by spirometry in all
patients. Measurements were repeated after inhalation of salbutamol in order to
evaluate bronchodilator response. There was a strong corelation between inverse
Rint and forced expiratory volume in one second (FEV1) (r = 0.8, p< 0.001)
and fair correlations between the inverse Rint and mid expiratory ﬂow (MEF)
(r = 0.74 p< 0.001) and between inverse Rint and body mass index (BMI) (r = 0.62
p< 0.001). The accuracy of bronchodilator response by the IT was tested through the
ROC (reciever operating curve), comparing results with spirometry bronchodilator
response. An area of 0.75 under the curve was obtained, for the cutoff point
of −28% of Rint, achieving a sensitivity of 66% and a speciﬁcity of 82%. The
ﬁndings suggest that Rint shows good correlation with spirometry parameters,
although the IT is not sufﬁciently acurate to replace spirometry in the evaluation
of bronchodilator response.
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Aims: To evaluate relation of oxidative stress markers (MOS) in exhaled breath
condensate (EBC) and development of pulmonary function (forced expiratory
volume in 1 sec.; FEV1) and nutritional status (body mass index; BMI) parameters
in CF patients.
Methods: 25 CF patients (14 males) with mean age 24.1 years were examined.
FEV1, BMI and EBC MOS were evaluated at the beginning of the study. EBC was
collected using ECoScreen condenser. Examined MOS included sum od nitrites
and nitrates (NOx) and 8-isoprostane (8-IP) and were assayed using liquid chro-
matography and ELISA method, respectively. FEV1 and BMI were examined also
after one-year follow-up and their differences from initial values were calculated
and correlated with EBC MOS using stepwise regressions.
Results: Mean EBC concentrations of NOx and 8-IP were 13.8 mmol/ml and
16.0 pg/ml, respectively. Mean FEV1 and BMI values changed from 64.0 to 57.9.%
pred. and from 21.9 to 22.0 kg/m2, respectively. Change in FEV1 correlated with
initial EBC 8-IP concentration (p = 0.05) and change in BMI with initial EBC NOx
concentration (p = 0.039). No other correlations were observed.
Conclusions: We found weak correlation of EBC MOS and pulmonary function
and nutritional status development in CF patients.
Supported by grants of MZ CR NR8304−3 and VZ642036405.
233 Decline in pulmonary function after introduction of macrolide
maintenance therapy
J.M.W. van den Berg1, M.M.J. van den Berg1, E.B. Wilms2, R.W. Brimicombe3,
H.G.M. Heijerman1. 1Haga Teaching Hospital, Adult Cystic Fibrosis Centre, The
Hague, Netherlands; 2Haga Teaching Hospital, The Hague Hospital Pharmacy,
The Hague, Netherlands; 3Haga Teaching Hospital, Dept. of Microbiology, The
Hague, Netherlands
Background: Chronic Pseudomonas aeruginosa (PA) infection in cystic ﬁbrosis
(CF) patients is associated with increased decline in pulmonary functions. In 1998
macrolide maintenance therapy (MMT) was introduced in our clinic as adjuvant
to inhalation antibiotics in CF patients with chronic PA infection. In this study we
investigated the effects of MMT on decline in pulmonary function.
Methods: Adult CF patients with chronic PA infection and MMT were compared
to CF patients without chronic PA infection. Patients with infection with B. cepacia
complex, S. maltophilia, or A. xylosidans were excluded. Developments in pul-
monary function, body mass index (BMI), and hospitalisation between 2000 and
2007 were investigated retrospectively.
Results: A total of 64 CF patients with chronic PA infection were included and
compared to 23 CF patients without chronic PA infection. Median age in 2000
was 28.5 and 30.9 years, respectively. BMI was comparable throughout the years.
Median number of in-hospital days was higher in patients with chronic PA infection
(19 versus 0 days, p = 0.001). At baseline median forced expiratory volume in 1
second as % of predicted (FEV1) was lower in patients with chronic PA infection
(62.3% versus 79.0%, p< 0.001), but the rate of decline in FEV1 over the years,
estimated by linear mixed models, was not higher (1.28% versus 1.31% decline per
year, p = 0.722).
Conclusion: The introduction of MMT in patients chronically infected with PA
resulted in a lower yearly decline in pulmonary function compared to data in
literature. The observed decline is comparable to patients without chronic PA
infection.
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Objectives: To assess the impact of early diagnosis in the development of bron-
chopulmonary disease in school age patients (5−8 years) with Cystic Fibrosis.
Methodology: We selected those with sputum cultures including one culture per
month. We compared 2 cohorts of patients: Group ED: Early detection (<2 months:
prenatal diagnosis + neonatal screening + early clinical diagnosis), and DD: delayed
diagnosis. We reviewed microbiological parameters, lung function, lung CT and
hospitalizations for pulmonary exacerbation.
Results: We collected 29 patients, 18 in the DP group and 11 in the DD group.
We analyzed 602 sputum, 40.7% were positive, the percentage was lower in the ED
group (31.9% vs 53.7%) (p< 0.0001). In both groups, Staphylococcus aureus was
the most prevalent, being signiﬁcantly more frequent in the DD group (p = 0.005),
whereas Pseudomonas aeruginosa was in the DD group (p = 0.13). 63.6% of patients
in the DD group were chronic carriers of Staphylococcus Aureus against 38% of the
ED group, and 9% carriers of Pseudomonas aeruginosa and Burkholderia cepacia
complex in the DD group vs 0% in group DE. No differences in lung CT between
groups were found. Lung function was normal in 93.3% of the ED group compared
with 75% of the DD group. DD group had more hospital admissions.
Conclusions: We observed differences in the number of positive cultures, iso-
lated germ type, presence of chronic carriers, respiratory functional changes and
pulmonary exacerbations. All this makes us support that early diagnosis, may
improve the morbidity of cystic ﬁbrosis by preventing or delaying the same
bronchopulmonary disease.
